Muscle relaxers aren’t a first-line migraine treatment, and most aren’t Food and Drug Administration (FDA) approved for migraine. If prescribed, it’s usually off-label for symptom relief when other ...

Please provide your email address to receive an email when new articles are posted on . Healio has compiled the most-read news in pulmonology posted in October. Highlights include a link found between ...

Please provide your email address to receive an email when new articles are posted on . In 44 studies, muscle relaxants showed benefit for only a small subset of pain syndromes. The findings suggest ...

The strongest evidence for effectiveness was seen for skeletal muscle relaxants used for trigeminal neuralgia, neck pain, and painful cramps. HealthDay News — Long-term use of skeletal muscle ...

Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today. The ...

Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today. The ...

Although tens of millions of Americans turn to muscle relaxants for lower back pain relief, a new Australian review finds little evidence that such drugs actually work. That's the conclusion of a deep ...

Generic drug maker Meitheal Pharmaceuticals recalled one lot of cisatracurium besylate, a muscle relaxant, after what the Institute for Safe Medication Practices ...

A batch of muscle relaxant tablets has been recalled because the bottles may contain a higher dosage than listed on the label. The company notes in its recall advisory that taking too much of this ...

Muscle relaxants given to millions of patients during general anaesthesia are associated with an increased risk of serious breathing problems after surgery, finds a study published on bmj.com today.

LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global muscle relaxant drugs market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021.

As doctors shift to non-opioid pain relievers in response to the opioid epidemic, the results of a small but illuminating study raise concerns that one type of opioid alternative — muscle relaxants — ...